SADDLE BROOK, N.J.,
Nov. 17, 2011 /PRNewswire/ --
Herborium Group, Inc., (PK: HBRM) www.herborium.com, a Botanical
Therapeutics® company, announced today that it has recently
launched Social Media Campaign for its proprietary acne treatment
product AcnEase®.
Currently over 60 million individuals in the USA are diagnosed with acne problems, with 50%
of adult women and 25% of adult men developing acne symptoms at
some point in their life. There are over 17 million adults with
acne in the USA. The median age
for acne sufferers increased from 20.5 to 26.5 years of age. Acne
affects people of all ethnic backgrounds and skin types making it
one of the most universal health afflictions worldwide.
Dr. Agnes Olszewski, President
and CEO of Herborium, stated, "Our aggressive marketing campaign
includes an overhauled Facebook and Twitter presence. Additionally,
the Company has deployed a blog of highly educative content aimed
at establishing Herborium's position an expert in helping people
achieve clear and healthy skin in a natural and safe manner."
There are a lot of misconceptions about acne that actually
affect the efficacy of treatment. Herborium's approach based on
educating acne suffers and improving efficacy in treatment
through addressing these misconceptions will help to build a
strong brand and wide following, especially from adults suffering
from chronic acne.
Due to the difficulty in treating adult acne, most over the
counter products as well as alternative treatments do not target
this market. This creates a tremendous opportunity for AcnEase
which has shown positive results in over 85% of adult users. Adult
Acne market has many advantages-lower price sensitivity (larger
margin) and higher brand loyalty over a teen market being just its
two top characteristics. In addition treatment of adult acne
requires longer treatment time providing for more advantageous
revenues forecast.
By targeting a broad range of acne sufferers Herborium will
reinforce the Company's image as a Botanical Therapeutics Company
with expertise in natural medicine and natural personal/beauty
care. Since acne is both a disease and a social affliction, AcnEase
bridges the healthcare and personal care (beauty) markets providing
for revenues streams from both markets.
About AcnEase (www.acnease.com)
AcnEase® is a proprietary, all herbal, systemically acting
botanical therapeutic® targeting the symptoms of acne in both
females and males of all ages. Unlike many herbal products, AcnEase
has been validated through clinical testing. The results
demonstrated that approximately 95% of the patients with adolescent
acne responded positively to AcnEase. In adults with hormonal or
chronic acne the level of effectiveness was 85%. The overall
positive response rate to AcnEase was 91%. To date, after 5 plus
years on the market, Herborium has registered a 95.5% consumer
satisfaction rate for the AcnEase product.
About Herborium Group, Inc.
Herborium Group, Inc., a botanical therapeutics® company,
focuses on developing, licensing, and marketing proprietary,
botanical based medicinal products to consumers and healthcare
professionals. The Company business model focuses on emerging
market opportunities spearheaded by the growth of a new market
sector located between high-cost, high-risk, ethical
pharmaceuticals and commoditized classic nutraceuticals
(supplements). The Company uses clinical validation and a
proactive regulatory strategy based on the FDA Guidance for
Industry: Botanical Drug Products (FDA Guidance 2004) to establish
and maintain a differential advantage. The company secured a
pipeline of botanical ingredients based products in the areas of
Dermatology, Prostate Health (BPH), Liver Diseases and Women's and
Men's Health and selected sexual disorders. Herborium Group sells
its products in the United States,
the United Kingdom, and
continental Europe through a
network of distributors, specialty retailers, and e-commerce.
One of our most important responsibilities is to communicate
with shareholders in an open and direct manner. Comments are
based on current management expectations, and are
considered "forward-looking statements," generally
preceded by words such as "plans," "expects," "believes,"
"anticipates," or "intends." We cannot promise
future returns. Our statements reflect our best judgment at
the time, and we disclaim any obligation to update or alter
forward-looking statements as the result of new information or
future events. The Company urges investors to
review the risks and uncertainties contained within its filings
with the OTC Markets and/or Securities and Exchange
Commission
For more information please inquire:
DrAgnes@Herborium.com
SOURCE Herborium Group, Inc.
